Some error occured while loading the Quick View. Please close the Quick View and try reloading the page.
Diabetes mellitus is a group of metabolic diseases in which a person has high blood sugar, either because the body does not produce enough insulin, or because cells do not respond to the insulin that is produced.
This book is the first volume in the World Clinics: Diabetology series. It provides diabetologists with the most recent developments in the diagnosis and treatment of Type 2 Diabetes Mellitus. Beginning with an introduction to dietary management and physical activity, the following sections discuss the advantages and disadvantages of different types of drugs used in the management of diabetes. New drug classes are covered in depth and each article is followed by a comment from the editors highlighting the key features of the topic.
Key points
- Provides diabetologists with most recent developments in diagnosis and treatment of Type 2 Diabetes Mellitus
- Covers numerous different drug types
- New drug classes discussed in depth
- Editors’ comment highlights key points in each article
V Mohan (Editor in Chief) MD FRCP PhD DSc FNASc FASc FNA
Chairman & Chief Diabetelogist, Dr. Mohan’s Diabetes Specialities Centre; Director & Chief of Diabetes Research, Madras Diabetes Research Foundation, ICMR Advanced Centre for Genomics of Diabetes, Chennai, Tamil Nadu, India
Ranjit Unnikrishnan MD Dip Diab (UK)
Vice Chairman & Consultant Diabetologist, Dr. Mohan's Diabetes Specialities Centre; Madras Diabetes Research Foundation, Chennai, Tamil Nadu, India
- Dietary Management
- Physical activity in diabetes
- Sulphonylurea
- Metformin: Old wine in new bottle -the evidence based first line agent in type 2 diabetes
- Alpha Glucosidase
- Pioglitazone
- DPP IV inhibitors
- GLP – 1 analogues
- Insulin in T2DM
- Insulin pumps in T2DM
- SGLT2 inhibitors
- T2DM in children
- Role of Insulin analogs in type 2 diabetes
- SMBG in T2DM